Blood test helps guide treatment and can impact quality of life for breast cancer patients

Washington, DC -- With the goal of tailoring cancer interventions for the individual, researchers at the Lombardi Comprehensive Cancer Center at Georgetown have published the results of a prospective study that validates the use of a simple blood test to help doctors more reliably assess treatment effectiveness for patients with metastatic breast cancer.

Read the whole article on Science Blog

More from Science Blog